379 related articles for article (PubMed ID: 31229399)
1. GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis.
Han Y; Li Y; He B
Reprod Biomed Online; 2019 Aug; 39(2):332-342. PubMed ID: 31229399
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
Ma R; Ding X; Wang Y; Deng Y; Sun A
Medicine (Baltimore); 2021 Jun; 100(23):e26295. PubMed ID: 34115034
[TBL] [Abstract][Full Text] [Related]
3. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Xing C; Li C; He B
J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
[TBL] [Abstract][Full Text] [Related]
4. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H; Chiovato L; Nappi RE
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2695-709. PubMed ID: 32442310
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Oral Antidiabetic Drugs on Improving the Endocrine and Metabolic States in Women with Polycystic Ovary Syndrome: A Systematic Review and Network Meta-analysis.
Yang S; Zhao L; He W; Mi Y
Drugs; 2022 Sep; 82(14):1469-1480. PubMed ID: 36129662
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
Tzotzas T; Karras SN; Katsiki N
Curr Vasc Pharmacol; 2017; 15(3):218-229. PubMed ID: 28003008
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
Bader S; Bhatti R; Mussa B; Abusanana S
Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of metformin combined with simvastatin in the treatment of polycystic ovary syndrome: A meta-analysis and systematic review.
Liu Y; Shao Y; Xie J; Chen L; Zhu G
Medicine (Baltimore); 2021 Aug; 100(31):e26622. PubMed ID: 34397797
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials.
Facchinetti F; Orrù B; Grandi G; Unfer V
Gynecol Endocrinol; 2019 Mar; 35(3):198-206. PubMed ID: 30614282
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.
Niafar M; Pourafkari L; Porhomayon J; Nader N
Arch Gynecol Obstet; 2016 Mar; 293(3):509-15. PubMed ID: 26660657
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.
Lamos EM; Malek R; Davis SN
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):401-408. PubMed ID: 28276778
[TBL] [Abstract][Full Text] [Related]
13. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
14. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
[TBL] [Abstract][Full Text] [Related]
15. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
16. The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective.
Jensterle M; Janez A; Fliers E; DeVries JH; Vrtacnik-Bokal E; Siegelaar SE
Hum Reprod Update; 2019 Jul; 25(4):504-517. PubMed ID: 31260047
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.
Sun J; Yuan Y; Cai R; Sun H; Zhou Y; Wang P; Huang R; Xia W; Wang S
BMJ Open; 2015 Mar; 5(3):e007280. PubMed ID: 25818277
[TBL] [Abstract][Full Text] [Related]
18. The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Lyu X; Lyu T; Wang X; Zhu H; Pan H; Wang L; Yang H; Gong F
Int J Endocrinol; 2021; 2021():6616693. PubMed ID: 33679973
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials.
Meng J; Zhu Y
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():19-24. PubMed ID: 33338947
[TBL] [Abstract][Full Text] [Related]
20. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
Patel R; Shah G
Curr Med Res Opin; 2017 Sep; 33(9):1545-1557. PubMed ID: 28058854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]